Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Testing reduces risk but does not eliminate it
coli Nissle 1917-derived minicells for targeted delivery of chemotherapeutic drug to hypoxic regions for cancer therapy
You May Also Like 4.6 (216) 4.7 (129) 4.5 (55) 4.6 (4419) 4.7 (5733) 4.7 (217) 4.6 (159) 4.5 (84) 4.6 (47) 4.7 (112) Shipped within 1 day
This applies to: 503A compounders: Until April 22, 2025 503B facilities: Until May 22, 2025 Important Caveat: The FDA may still take action regarding violations of any other statutory or regulatory requirements, such as to address findings that a product may be of substandard quality or otherwise unsafe
Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children
Gastroenterology 122 , 11131121 (2002)
US$ 25.74
US$ 26.31
US$ 28.85
US$ 24.31
US$ 28.95
US$ 28.74
